1. Home
  2. BLZE vs DERM Comparison

BLZE vs DERM Comparison

Compare BLZE & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

HOLD

Current Price

$15.66

Market Cap

218.8M

Sector

Technology

ML Signal

HOLD

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$7.11

Market Cap

194.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLZE
DERM
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.8M
194.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
BLZE
DERM
Price
$15.66
$7.11
Analyst Decision
Buy
Strong Buy
Analyst Count
6
3
Target Price
$7.60
$12.67
AVG Volume (30 Days)
4.5M
338.9K
Earning Date
05-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
58.56
34.72
EPS
N/A
N/A
Revenue
$145,835,000.00
$61,858,000.00
Revenue This Year
$10.16
$39.72
Revenue Next Year
$10.91
$63.24
P/E Ratio
N/A
N/A
Revenue Growth
14.27
10.20
52 Week Low
$3.26
$4.31
52 Week High
$16.59
$9.56

Technical Indicators

Market Signals
Indicator
BLZE
DERM
Relative Strength Index (RSI) 82.62 63.54
Support Level $3.93 $7.00
Resistance Level N/A $7.69
Average True Range (ATR) 1.21 0.44
MACD 0.68 0.06
Stochastic Oscillator 90.08 86.21

Price Performance

Historical Comparison
BLZE
DERM

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Share on Social Networks: